(Q37608234)

21 August 2017

1 reference

title

Budget-impact analyses: a critical review of published studies (English)

1 reference

21 August 2017

Ewa Orlewska

1

1 reference

21 August 2017

Laszlo Gulácsi

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

27

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

807-827

1 reference

Prevalence-based economic evaluation.

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11313770-000000000-00000

Budget impact model of rituximab after failure of one or more TNFalpha inhibitor therapies in the treatment of rheumatoid arthritis.

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage

1 reference

12 December 2020

Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland

1 reference

12 December 2020

[Economic impact of the taxus coronary stent: implications for the Spanish healthcare system]

1 reference

12 December 2020

[Budgetary impact of pneumococcal conjugate vaccination of newborns]

1 reference

12 December 2020

Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers.

1 reference

12 December 2020

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients.

1 reference

12 December 2020

Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer

1 reference

12 December 2020

Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise

1 reference

12 December 2020

The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

1 reference

12 December 2020

National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

1 reference

12 December 2020

Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations

1 reference

12 December 2020

Developing guidance for budget impact analysis

1 reference

12 December 2020

[Methodology of new pharmacoeconomic method "impact on hospital budget" by the example of local hemostatic agents in abdominal surgery]

1 reference

12 December 2020

Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service

1 reference

12 December 2020

The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis

1 reference

12 December 2020

The budget impact of endoscopic screening for esophageal varices in cirrhosis

1 reference

12 December 2020

Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan.

1 reference

12 December 2020

Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan

1 reference

12 December 2020

Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis

1 reference

12 December 2020

[Outpatient female stress urinary incontinence surgery: budget impact study]

1 reference

12 December 2020

Health plan budget impact analysis for pimecrolimus.

1 reference

12 December 2020

Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1.

1 reference

12 December 2020

A budget-impact and cost-effectiveness model for second-line treatment of major depression.

1 reference

12 December 2020

The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses

1 reference

12 December 2020

Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals .

1 reference

12 December 2020

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations

1 reference

12 December 2020

Impact analysis of drug-eluting stent in the unified health system budget.

1 reference

12 December 2020

Budget impact analysis: review of the state of the art.

1 reference

12 December 2020

Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis

1 reference

12 December 2020

Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries.

1 reference

12 December 2020

Budget impact of tegaserod on a managed care organization formulary.

1 reference

12 December 2020

Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials.

1 reference

12 December 2020

Calculation of prevalence with Markov models: budget impact analysis of thrombolysis for stroke.

1 reference

12 December 2020

[Budget impact analysis of a blood saving program for urgent traumatological surgery].

1 reference

12 December 2020

Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries

1 reference

12 December 2020

Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada

1 reference

12 December 2020

[Budget impact analysis of the treatment of chronic hepatitis C in a hospital].

1 reference

12 December 2020

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

1 reference

12 December 2020

10.2165/11313770-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1027460862

0 references

1 reference